Collectively, RA patients with myopenia and elevated myostatin levels exhibited the most substantial radiographic progression, the lowest likelihood of remission, and the poorest long-term outcomes52 (Fig. 2). The gene discussed is MSTN; the disease is rheumatoid arthritis.